Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Frontiers in Endocrinology
|
September 7, 2018
Metformin: Focus on Melanoma
Emilie Jaune, Stéphane Rocchi
Autophagy
|
October 30, 2016
New anti-cancer molecules targeting HSPA5/BIP to induce endoplasmic reticulum stress, autophagy and apoptosis
Michaël Cerezo, Stéphane Rocchi
Cell Death & Disease
|
November 12, 2020
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Michaël Cerezo, Stéphane Rocchi
Cancers
|
February 11, 2023
Novel Therapeutic Targets in Melanoma
Michaël Cerezo, Stéphane Rocchi
Journal of Clinical Pathology
|
December 20, 2019
Comment on 'Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy'
Thomas Botton, Thierry Passeron, Stéphane Rocchi
Oncoscience
|
January 21, 2017
Targeting BIP to induce Endoplasmic Reticulum stress and cancer cell death
Michaël Cerezo, Rachid Benhida, Stéphane Rocchi
Pigment Cell & Melanoma Research
|
May 28, 2014
Is it time to test biguanide metformin in the treatment of melanoma?
Michael Cerezo, Tijana Tomic, Robert Ballotti, et al.
Oncotarget
|
October 21, 2016
Mechanism of melanoma cells selective apoptosis induced by a photoactive NADPH analogue
Florian Rouaud, Jean-Luc Boucher, Anny Slama-Schwok, et al.
European Journal of Medicinal Chemistry
|
August 7, 2021
Biguanides drugs: Past success stories and promising future for drug discovery
Oleksandr Grytsai, Iuliia Myrgorodska, Stéphane Rocchi, et al.
Medicinal Research Reviews
|
August 30, 2016
Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges
Antoine Millet, Anthony R Martin, Cyril Ronco, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Frontiers in Endocrinology
|
September 7, 2018
Metformin: Focus on Melanoma
Emilie Jaune, Stéphane Rocchi
Autophagy
|
October 30, 2016
New anti-cancer molecules targeting HSPA5/BIP to induce endoplasmic reticulum stress, autophagy and apoptosis
Michaël Cerezo, Stéphane Rocchi
Cell Death & Disease
|
November 12, 2020
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Michaël Cerezo, Stéphane Rocchi
Cancers
|
February 11, 2023
Novel Therapeutic Targets in Melanoma
Michaël Cerezo, Stéphane Rocchi
Journal of Clinical Pathology
|
December 20, 2019
Comment on 'Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy'
Thomas Botton, Thierry Passeron, Stéphane Rocchi
Oncoscience
|
January 21, 2017
Targeting BIP to induce Endoplasmic Reticulum stress and cancer cell death
Michaël Cerezo, Rachid Benhida, Stéphane Rocchi
Pigment Cell & Melanoma Research
|
May 28, 2014
Is it time to test biguanide metformin in the treatment of melanoma?
Michael Cerezo, Tijana Tomic, Robert Ballotti, et al.
Oncotarget
|
October 21, 2016
Mechanism of melanoma cells selective apoptosis induced by a photoactive NADPH analogue
Florian Rouaud, Jean-Luc Boucher, Anny Slama-Schwok, et al.
European Journal of Medicinal Chemistry
|
August 7, 2021
Biguanides drugs: Past success stories and promising future for drug discovery
Oleksandr Grytsai, Iuliia Myrgorodska, Stéphane Rocchi, et al.
Medicinal Research Reviews
|
August 30, 2016
Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges
Antoine Millet, Anthony R Martin, Cyril Ronco, et al.
Page
of 7